Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human GPBA Receptor Y89A) Stable Cell Line which GPBA Mutant Y89A receptor stably expressed in CHO-K1 cells.
Description
CHO-K1-Tg(Human GPBA Receptor Y89A) Stable Cell Line was engineered to express the receptor human GPBA receptor mutant Y89A (NM_170699). The GPBA receptor responds to bile acids and is involved in various physiological processes, including metabolic regulation, energy homeostasis, and immune responses. The Y89A mutation involves the substitution of tyrosine (Y) at position 89 with alanine (A). This cell line can be used to study receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Features
Minimally modified GPCRs directly selected in functional assays;
Strict quality control;
Parental and orthologous cell lines are available.
Applications
Receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPBA mutant Y89A
Receptor Family
Bile Acid
Species
Human
Parental Cell Line
CHO-K1
Transfection
Expression vector containing full-length human GPBAR1 cDNA with Y89A mutation with FLAG tag sequence at N-terminus
Gene
NM_170699
Background
The GPBA receptor plays crucial roles in various physiological processes, including metabolic regulation and immune responses. The Y89A mutation, involving the substitution of tyrosine with alanine at position 89, can significantly impact the receptor's structure, ligand binding, and signaling functions. Research into this mutation can provide insights into its physiological and pathological consequences, potentially guiding therapeutic strategies for related disorders.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.